These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14553948)

  • 1. Microsatellite alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Koo SH; Ihm CH; Kwon KC; Lee JS; Park JW; Kim JW
    Cancer Genet Cytogenet; 2003 Oct; 146(2):139-44. PubMed ID: 14553948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Koo SH; Ihm CH; Kwon KC; Park JW; Kim JM; Kong G
    Cancer Genet Cytogenet; 2001 Oct; 130(1):22-8. PubMed ID: 11672769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelotypic characteristics of thorotrast-induced intrahepatic cholangiocarcinoma: comparison to liver cancers not associated with thorotrast.
    Liu D; Wada I; Tateno H; Ogino D; Suzuki M; Li L; Lu W; Kojiro M; Fukayama M; Okabe H; Fukumoto M
    Radiat Res; 2004 Feb; 161(2):235-43. PubMed ID: 14731065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
    Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH
    Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal imbalances in Korean intrahepatic cholangiocarcinoma by comparative genomic hybridization.
    Uhm KO; Park YN; Lee JY; Yoon DS; Park SH
    Cancer Genet Cytogenet; 2005 Feb; 157(1):37-41. PubMed ID: 15676145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
    Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
    J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive allelotyping of human intrahepatic cholangiocarcinoma.
    Momoi H; Okabe H; Kamikawa T; Satoh S; Ikai I; Yamamoto M; Nakagawara A; Shimahara Y; Yamaoka Y; Fukumoto M
    Clin Cancer Res; 2001 Sep; 7(9):2648-55. PubMed ID: 11555575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular and cholangiolar carcinoma-derived cell lines reveal distinct sets of chromosomal imbalances.
    Wilkens L; Hammer C; Glombitza S; Müller DE
    Pathobiology; 2012; 79(3):115-26. PubMed ID: 22261732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic classification of combined hepatocellular-cholangiocarcinoma.
    Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
    Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelotype analysis of intrahepatic cholangiocarcinoma.
    Kang YK; Kim YI; Kim WH
    Mod Pathol; 2000 Jun; 13(6):627-31. PubMed ID: 10874666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsatellite alterations in liver fluke related cholangiocarcinoma are associated with poor prognosis.
    Limpaiboon T; Krissadarak K; Sripa B; Jearanaikoon P; Bhuhisawasdi V; Chau-in S; Romphruk A; Pairojkul C
    Cancer Lett; 2002 Jul; 181(2):215-22. PubMed ID: 12175538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copy number aberrations in combined hepatocellular carcinoma and cholangiocarcinoma.
    You HL; Weng SW; Li SH; Wei YC; Sheu JJ; Chen CM; Huang WT
    Exp Mol Pathol; 2012 Jun; 92(3):281-6. PubMed ID: 22366251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation inactivation of Nijmegen breakage syndrome gene (NBS1) in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
    Wang Y; Hong Y; Li M; Long J; Zhao YP; Zhang JX; Li Q; You H; Tong WM; Jia JD; Huang J
    PLoS One; 2013; 8(12):e82426. PubMed ID: 24349281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed hepatocellular cholangiocarcinoma tumors: Cholangiolocellular carcinoma is a distinct molecular entity.
    Moeini A; Sia D; Zhang Z; Camprecios G; Stueck A; Dong H; Montal R; Torrens L; Martinez-Quetglas I; Fiel MI; Hao K; Villanueva A; Thung SN; Schwartz ME; Llovet JM
    J Hepatol; 2017 May; 66(5):952-961. PubMed ID: 28126467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma.
    Murugesan K; Sharaf R; Montesion M; Moore JA; Pao J; Pavlick DC; Frampton GM; Upadhyay VA; Alexander BM; Miller VA; Javle MM; Bekaii Saab TS; Albacker LA; Ross JS; Ali SM
    JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34476330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of loss of heterozygosity on chromosome 17 in intrahepatic cholangiocarcinoma].
    Kim HJ; Kang CD; Lee SJ; Cho SJ; Kim JS
    Korean J Gastroenterol; 2006 Sep; 48(3):188-94. PubMed ID: 17047434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple genetic alterations involved in the tumorigenesis of human cholangiocarcinoma: a molecular genetic and clinicopathological study.
    Cong WM; Bakker A; Swalsky PA; Raja S; Woods J; Thomas S; Demetris AJ; Finkelstein SD
    J Cancer Res Clin Oncol; 2001; 127(3):187-92. PubMed ID: 11260864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma.
    Momoi H; Itoh T; Nozaki Y; Arima Y; Okabe H; Satoh S; Toda Y; Sakai E; Nakagawara K; Flemming P; Yamamoto M; Shimahara Y; Yamaoka Y; Fukumoto M
    J Hepatol; 2001 Aug; 35(2):235-44. PubMed ID: 11580146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYH Y165C and G382D mutations in hepatocellular carcinoma and cholangiocarcinoma patients.
    Baudhuin LM; Roberts LR; Enders FT; Swanson RL; Mettler TA; Aderca I; Stadheim LM; Highsmith WE
    J Cancer Res Clin Oncol; 2006 Mar; 132(3):159-62. PubMed ID: 16292541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
    Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
    Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.